Celgene buys into Mesoblast’s stem cell pipeline in regenerative med pact – FierceBiotech
The Australian Financial Review |
Celgene buys into Mesoblast's stem cell pipeline in regenerative med pact
FierceBiotech Celgene has stepped up with a deal to buy a $45 million chunk of Mesoblast's stock at a premium price in exchange for a front row seat on the Australian biotech's stem cell pipeline and a preferred spot at the bargaining table if it follows up with a … Stem cell pioneer lures big pharma Shares in this Australian stem cell company are going nuts on an investment … Mesoblast Shoots To A 4-Year High On News Of Celgene Corporation Buying … |
